LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18 | 0.0% | 261 | 0.0% | 0.00% | – |
| Q2 2023 | $18 | +38.5% | 261 | 0.0% | 0.00% | – |
| Q1 2023 | $13 | 0.0% | 261 | 0.0% | 0.00% | – |
| Q4 2022 | $13 | -99.8% | 261 | +31.2% | 0.00% | – |
| Q3 2022 | $8,000 | -27.3% | 199 | 0.0% | 0.00% | – |
| Q2 2022 | $11,000 | -93.6% | 199 | -95.8% | 0.00% | -100.0% |
| Q1 2022 | $172,000 | +36.5% | 4,716 | +74.9% | 0.00% | 0.0% |
| Q4 2021 | $126,000 | +2000.0% | 2,696 | +2373.4% | 0.00% | – |
| Q3 2021 | $6,000 | +200.0% | 109 | +172.5% | 0.00% | – |
| Q2 2021 | $2,000 | +100.0% | 40 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 40 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $89,605,000 | 22.89% |
| Paradigm Biocapital Advisors LP | 978,596 | $53,823,000 | 10.73% |
| FengHe Fund Management Pte. Ltd. | 475,263 | $26,139,000 | 10.25% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,222,342 | $67,229,000 | 9.65% |
| HHLR ADVISORS, LTD. | 4,436,617 | $244,014,000 | 5.23% |
| Iron Triangle Partners LP | 495,329 | $27,243,000 | 3.53% |
| Parkman Healthcare Partners LLC | 117,807 | $6,479,000 | 2.39% |
| AtonRa Partners | 28,172 | $1,549,000 | 1.42% |
| Vivo Capital, LLC | 244,375 | $13,441,000 | 1.35% |
| Avidity Partners Management LP | 1,000,000 | $55,000,000 | 1.26% |